125 related articles for article (PubMed ID: 12458145)
1. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles.
Wroblewska MM; Swoboda-Kopec E; Rokosz A; Krawczyk E; Marchel H; Luczak M
Int J Antimicrob Agents; 2002 Dec; 20(6):472-5. PubMed ID: 12458145
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
3. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
5. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
Pfaller MA; Jones RN; Messer SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1998 May; 31(1):327-32. PubMed ID: 9597393
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
Lei J; Xu J; Wang T
J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
8. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
Zhang X; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Silva V; Alvarado D; Diaz MC
Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
[TBL] [Abstract][Full Text] [Related]
10. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Zhao M; Zhou ZT
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
Sojakova M; Liptajova D; Borovsky M; Subik J
Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
13. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Pfaller MA; Messer SA; Houston A; Rangel-Frausto MS; Wiblin T; Blumberg HM; Edwards JE; Jarvis W; Martin MA; Neu HC; Saiman L; Patterson JE; Dibb JC; Roldan CM; Rinaldi MG; Wenzel RP
Diagn Microbiol Infect Dis; 1998 May; 31(1):289-96. PubMed ID: 9597389
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance in neonatal intensive care units in Argentina.
Giusiano G; Mangiaterra M; Rojas F; Gómez V
J Chemother; 2005 Jun; 17(3):347-50. PubMed ID: 16038532
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Metzger S; Hofmann H
Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter study on nosocomial candidiasis in the Republic of Argentina].
Rodero L; Davel G; Córdoba S; Soria M; Canteros C; Hochenfellner F
Rev Argent Microbiol; 1999; 31(3):114-9. PubMed ID: 10509389
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients.
Sharifynia S; Rezaie S; Mohamadnia A; Mortezaee V; Hadian A; Seyedmousavi S
Med Mycol; 2019 Jan; 57(1):127-131. PubMed ID: 29618069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
